Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2003
03/26/2003CN1404869A Medicine for treating burn and scald and preparation method thereof
03/26/2003CN1404867A Chinese medicine for treating hyperplasia of mammary glands
03/26/2003CN1404857A Tea for giving-up smoking
03/26/2003CN1404855A Medicine for treating scald
03/26/2003CN1404851A Medicine for treating kidney disease
03/26/2003CN1404842A Chemical for preventing mycosis of silkworm and its preparation method thereof
03/26/2003CN1103599C Medicinal composition for treating asthma and its preparation method
03/26/2003CN1103596C Burn-treating medicine powder and its preparation
03/26/2003CN1103595C Chinese medicine preparation for postpartum recovery and its preparing process
03/25/2003USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537807 Cells designated CD7+CD34-Lin-; use in treatment of genetic and infectious diseases; identification of substances to promote growth, engraftment, and differentiation of stem cells
03/25/2003US6537806 Compositions and methods for treating diabetes
03/25/2003US6537805 Self-deleting vectors
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537591 Aquatic animal treatment method and composition containing Pimenta extract
03/25/2003US6537588 Food-induced antisecretory proteins in egg yolk
03/25/2003US6537587 Compositions containing muscle-derived active agents
03/25/2003US6537570 Method of biological control
03/25/2003US6537559 Staphylococcus aureus antigen-containing whole cell vaccine
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537544 Oatmeal gruel fermiented with strains of lactobacillus plantarum JI:1 and species AC:3; prophylaxis or treatment of disturbances in equine intestinal microflora and gastritis
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537265 Method for nasal application of a medicinal substance
03/25/2003CA2270841C Compositions with analgesic, antipyretic and antiinflammatory properties
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023020A1 Pancreatic small cells and uses thereof
03/20/2003WO2003023018A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022988A2 Adipose-derived stem cells and lattices
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022870A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003WO2003022312A1 Method for improving oxygen transport by stored red blood cells
03/20/2003WO2003022305A1 Method for treating coumarin-induced hemorrhage
03/20/2003WO2003022293A1 Novel antimicrobial substance from human leukocytes
03/20/2003WO2003022288A1 Nutritional compositions for controlling blood glucose level
03/20/2003WO2003022255A2 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003WO2003022215A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2003000280A3 Abin-mediated hepatitis protection
03/20/2003WO2002098361A3 T cell induced tissue repair and regeneration
03/20/2003WO2002097065A3 Remodeling of somatic nuclei upon addition of pluripotent cell extracts
03/20/2003WO2002092792A3 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
03/20/2003WO2002074045A3 Production of pancreatic islet cells and delivery of insulin
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002053760A3 Chimeric cytolytic viruses for cancer treatment
03/20/2003WO2002047697A8 Fractions of snake blood, their preparation and use as therapeutic agents
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002024897A9 Conditionally replicating viral vectors and their use
03/20/2003WO2002017980A9 Methods and compositions for tissue regeneration
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030056233 Induction of psoriasis in animal model; obtain cells, transfer to transgenic rodent, administer cytokine, monitor development of skin disorder
03/20/2003US20030054998 Prolactin induced increase in neural stem cell numbers
03/20/2003US20030054973 Methods and compositions for the repair and/or regeneration of damaged myocardium
03/20/2003US20030054551 Amplification of neuronal stem cells; prepare nutrient broth, mix with modulator, inoculate with stem cells monitor propagation activity in cells
03/20/2003US20030054498 Recombinant vector for use in gene therapy for insulin-dependent diabetes mellitus and therapeutic composition thereof
03/20/2003US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054330 Mammalian erythrocytes for use in the storage for allographic and xenographic transfusions
03/20/2003US20030054035 Biodegradation membrane
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030053997 Expansion in situ; cognition activators
03/20/2003US20030053996 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053994 Genetic engineering; desroying infections; antitumor, anticancer agents
03/20/2003US20030053992 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003CA2497954A1 Pancreatic small cells and uses thereof
03/20/2003CA2472102A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460269A1 Alphavirus replicon vector systems
03/20/2003CA2460023A1 Method for treating coumarin-induced hemorrhage
03/20/2003CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003CA2459713A1 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459202A1 Adipose-derived stem cells and lattices
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2457092A1 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/19/2003WO2002024001A2 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292671A1 Method for obtaining characterised muscle-derived cell populations and uses
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292340A1 Transfection system
03/19/2003EP1292332A2 Adjuvants and processes to induce a specific type of immune response
03/19/2003EP1292329A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
03/19/2003EP1292325A1 Matrix protein compositions for dentin regeneration
03/19/2003EP1292321A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
03/19/2003EP1292319A2 Extracts from spermatophyte plants with antitumor activity
1 ... 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 ... 1259